PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of pharmscispringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSci. 2004 March; 6(1): 31–44.
Published online 2004 January 26. doi:  10.1208/ps060104
PMCID: PMC2750939

Polyethylene glycol-induced precipitation of interferon alpha-2a followed by vacuum drying: Development of a novel process for obtaining a dry, stable powder

Abstract

Feasibility studies were performed on the development of a novel process based on polyethylene glycol (PEG)-induced precipitation of proteins followed by vacuum drying in the presence of sugars to obtain dry protein powders. Apparent solubility of interferon alpha-2a (IFNα2a) was determined in the presence of various PEGs and the effect of solution pH, ionic strength, and temperature was investigated. IFNα2a precipitate was dried at a shelf temperature of 25°C at 100 mTorr either as it is or in the presence of mannitol and/or trehalose. The dried IFNα2a formulations were subjected to accelerated stability studies at 40°C (3 months), and the stability was compared with that of a similar lyophilized formulation. The results indicated that more than 90% of the protein could be precipitated using 10% wt/vol PEG the protein could be precipitated using 10% wt/vol PEG 1450 at pH 6.5 at a solution ionic strength of 71 mM. Vacuum drying of the precipitate only resulted in the formation of insoluble aggregates of IFNα2a; however, this was prevented by the addition of either mannitol or trehalose. The addition of excess mannitol resulted in low residual moisture content and better handling of the final dried product. Accelerated storage stability did not show any aggregation and showed less than 5% formation of oxidized IFNα2a in the dried formulation containing IFNα2a: trehalose: mannitol in a 1[ratio]10[ratio]100 wt/wt ratio upon storage at 40°C for 3 months. The stability of this vacuum dried formulation was comparable with that of a similar lyophilized formulation.

References

1. Manning MC, Patel K, Borchardt RT. Stability of protein pharmaceuticals. Pharm Res. 1989;6:903–918. doi: 10.1023/A:1015929109894. [PubMed] [Cross Ref]
2. Arakawa T, Prestrelski S, Kenney WC, Carpenter JF. Factors affecting short-term and long-term stabilities of proteins. Adv Drug Deliv Rev. 2001;46:307–326. doi: 10.1016/S0169-409X(00)00144-7. [PubMed] [Cross Ref]
3. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185:129–188. doi: 10.1016/S0378-5173(99)00152-0. [PubMed] [Cross Ref]
4. Ahern TJ, Manning MC, editors. Stability of Protein Pharmaceuticals, Part A: Chemical and Physical Pathways of Protein Degradation. New York, NY: Plenum Press; 1990.
5. Chen T. Formulation concerns of protein drug. Drug Dev Ind Pharm. 1992;18:1311–1354. doi: 10.3109/03639049209046331. [Cross Ref]
6. Pikal MJ. Freeze-drying of proteins: Process, formulation, and stability. In: Cleland JL, Langer R, editors. Formulation and Delivery of Proteins and Peptides. Washington, DC: American Chemical Society; 1994. pp. 120–133.
7. Wang W. Lyophilization and development of protein pharmaceuticals. Int J Pharm. 2000;203:1–60. doi: 10.1016/S0378-5173(00)00423-3. [PubMed] [Cross Ref]
8. Gomez G, Pikal MJ, Rodriguez-Homedo N. Effect of initial buffer composition on pH changes on far-from-equilibrium freezing of sodium phosphate buffer solutions. Pharm Res. 2001;18:90–97. doi: 10.1023/A:1011082911917. [PubMed] [Cross Ref]
9. Izutsu K, Heller MC, Randolph TW, Carpenter JF. Effect of salts and sugars on phase separation of polyvinylpyrrolidone-dextran solutions induced by freeze-concentration. J Chem Soc, Faraday Trans. 1998;94:411–417. doi: 10.1039/a704950a. [Cross Ref]
10. Gomez G. Crystallization-Related pH Changes During Freezing of Sodium Phosphate Buffer Solutions [dissertation]. Ann Arbor, MI: University of Michigan; 1995.
11. Strambini GB, Gabellieri E. Proteins in frozen, solution: Evidence of ice-induced partial unfolding. Biophys J. 1996;70:971–976. [PubMed]
12. Chang BS, Kendrick BS, Carpenter JF. Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. J Pharm Sci. 1996;85:1325–1330. doi: 10.1021/js960080y. [PubMed] [Cross Ref]
13. Franks F. Protein destabilization at low temperatures. In: Anfinsen CB, Edsall JT, Richards FM, Eisenberg DS, editors. Advances in Protein Chemistry: Protein Stability. New York, NY: Academic Press; 1995. pp. 105–137.
14. Mumenthaler M, Hsu CC, Pearlman R. Feasibility study on spray-drying protein pharmaceuticals: Recombinant human growth hormone and tissue-type plasminogen activator. Pharm Res. 1994;11:12–20. doi: 10.1023/A:1018929224005. [PubMed] [Cross Ref]
15. Maa YF, Nguyen P-A, Andya JD, et al. Effect of spray drying and subsequent processing conditions on residual moisture content and physical/biochemical stability of protein inhalation powders. Pharm Res. 1998;15:768–775. doi: 10.1023/A:1011983322594. [PubMed] [Cross Ref]
16. Mumenthaler M, Leuenberger H. Atmospheric spray-freeze-drying: A suitable alternative in freeze-drying technology. Int J Pharm. 1991;72:97–110. doi: 10.1016/0378-5173(91)90047-R. [Cross Ref]
17. Shenoy B, Wang Y, Shan W, Margolin AL. Stability of crystalline proteins. Biotechnol Bioeng. 2001;73:358–369. doi: 10.1002/bit.1069. [PubMed] [Cross Ref]
18. Winters MA, Knutson BL, Debenedetti PG, et al. Precipitation of proteins in supercritical carbon dioxide. J Pharm Sci. 1996;85:586–594. doi: 10.1021/js950482q. [PubMed] [Cross Ref]
19. Moshashaee S, Bisrat M, Forbes RT, Nyqvist H, York P. Supercritical fluid processing of proteins. I: Lysozyme precipitation from organic solution. Eur J Pharm Sci. 2000;11:239–245. doi: 10.1016/S0928-0987(00)00108-1. [PubMed] [Cross Ref]
20. Franks F, Hatley R. Storage of materials. European patent application 90301561.8.1989.
21. Mattern M, Winter G, Rudolph R, Lee G. Formulation of proteins in vacuum-dried glasses. Part 1. Improved vacuum-drying of sugars using crystallizing amino acids. Eur J Pharm Biopharm. 1997;44:177–185. doi: 10.1016/S0939-6411(97)00070-2. [Cross Ref]
22. Brohnstein V. Scalable long-term shelf preservation of sensitive biological solutions and suspensions US patent 6 509 146. January 21, 2003.
23. Scopes RK. Separation by precipitation. In: Cantor CR, editor. Protein Purification: Principles and Practice. 2nd ed. New York, NY: Springer-Verlag Press; 1987. pp. 41–71.
24. Melander W, Horvarth C. Salt effects on hydrophobic interactions in precipitation and chromatography of proteins: An interpretation of the lyotropic series. Arch Biochem Biophys. 1977;183:200–215. doi: 10.1016/0003-9861(77)90434-9. [PubMed] [Cross Ref]
25. Askonas BA. The use of organic solvents at low temperatures for the separation of enzymes: Application to aqueous rabbit muscle extract. Biochem J. 1951;48:42–48. [PubMed]
26. Polson A, Potgieter GM, Largier JF, Mears GEF, Jouber FJ. The fractionation of protein mixtures by linear polymers of high molecular weight. Biochim Biophys Acta. 1964;82:463–475. [PubMed]
27. Zeppezauer M, Brishammar S. Protein precipitation by uncharged water soluble polymers. Biochim Biophys Acta. 1965;94:581–590. doi: 10.1016/0926-6585(65)90069-5. [PubMed] [Cross Ref]
28. Sternberg M, Hershberger D. Separation of proteins with polyacrylic acids. Biochim Biophys Acta. 1974;342:195–206. [PubMed]
29. Iverius PH, Laurent TC. Precipitation of some plasma proteins by the addition of dextran or polyethylene glycol. Biochim Biophys Acta. 1967;133:371–377. [PubMed]
30. Haire RN, Tisel WA, White JG, Rosenberg A. On the precipitation of proteins by polymers: the hemoglobin-polyethylene glycol system. Biopolymers. 1984;23:2761–2779. doi: 10.1002/bip.360231206. [PubMed] [Cross Ref]
31. Ingham KC. Precipitation of proteins with polyethylene glycol: Characterization of albumin. Arch Biochem Biophys. 1978;186:106–112. doi: 10.1016/0003-9861(78)90469-1. [PubMed] [Cross Ref]
32. Ingham KC. Protein precipitation with polyethylene glycol. In: Jakoby WB, editor. Methods in Enzymology: Enzyme Purification and Related Techniques Part C. vol 104. Orlando, FL: Academic Press; 1984. pp. 351–355.
33. Miekka SI, Ingham KC. Influence of self-association of proteins on their precipitation by polyethylene glycol. Arch Biochem Biophys. 1978;191:525–536. doi: 10.1016/0003-9861(78)90391-0. [PubMed] [Cross Ref]
34. Miekka SI, Ingham KC. Influence of hetero-association on the precipitation of proteins by poly(ethylene glycol) Arch Biochem Biophys. 1980;203:630–641. doi: 10.1016/0003-9861(80)90220-9. [PubMed] [Cross Ref]
35. Atha DH, Ingham KC. Mechanism of precipitation of proteins by polyethylene glycols: Analysis in terms of excluded volume. J Biol Chem. 1981;256:12108–12117. [PubMed]
36. Arakawa T, Timasheff SN. Mechanism of poly(ethylene glycol) interaction of proteins. Biochemistry. 1985;24:6756–6762. doi: 10.1021/bi00345a005. [PubMed] [Cross Ref]
37. Klaus W, Gsell B, Labhardt AM, Wipf B, Senn H. The three-dimensional high resolution structure of human interferon α-2a determined by heteronuclear NMR spectroscopy in solution. J Mol Biol. 1997;274:661–675. doi: 10.1006/jmbi.1997.1396. [PubMed] [Cross Ref]
38. Gross G, Del Terzo S, Kumar SK. Stabilized interferon alpha solutions. US Patent 5 762 923; 1998.
39. McPherson A. Crystallization of macromolecules: General principles. In: Wyckoff HW, Hirs CHW, Timasheff SN, editors. Methods in Enzymology, 114 (Diffraction Methods in Biological Macromolecules Part A) Orlando, FL: Academic Press; 1985. pp. 112–120.
40. Smatanova IK. Crystallization of biological macromolecules. Materials Structure. 2002;9:14–15.
41. Dong A, Prestrelski SJ, Allison SD, Carpenter JF. Infrared spectroscopic studies of lyophilization and temperature induced protein aggregation. J Pharm Sci. 1995;84:415–424. doi: 10.1002/jps.2600840407. [PubMed] [Cross Ref]
42. Heller MC, Carpenter JF, Randolph TW. Manipulation of lyophilization-induced phase separation: Implications for pharmaceutical proteins. Biotechnol Prog. 1997;13:590–596. doi: 10.1021/bp970081b. [PubMed] [Cross Ref]
43. Arakawa T, Timasheff SN. Theory of protein solubility. In: Wyckoff HW, Hirs CHW, Timasheff SN, editors. Methods in Enzymology, 114 (Diffraction Methods in Biological Macromolecules Part A) Orlando, FL: Academic Press; 1985. pp. 49–77.
44. Dong A, Huang P, Caughey WS. Protein secondary structures in water from second-derivative amide I infrared spectra. Biochemistry. 1990;29:3303–3308. doi: 10.1021/bi00465a022. [PubMed] [Cross Ref]
45. Bandekar J. Amide modes and protein conformation. Biochim Biophys Acta. 1992;1120:123–143. [PubMed]
46. Prestrelski SJ, Tedischi N, Arakawa T, Carpenter JF. Dehydration-induced conformational transitions in proteins and their inhibition by stabilizers. Biophys J. 1993;65:661–671. [PubMed]
47. Carpenter JF, Crowe JH. An infrared spectroscopic study of the interaction of carbohydrates with dried proteins. Biochemistry. 1989;28:3916–3922. doi: 10.1021/bi00435a044. [PubMed] [Cross Ref]
48. Allison SD, Chang B, Randolph TW, Carpenter JF. Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding. Arch Biochem Biophys. 1999;365:289–298. doi: 10.1006/abbi.1999.1175. [PubMed] [Cross Ref]
49. Izutsu K, Yoshioka S, Terao T. Effect of mannitol crystallization on the stabilization of enzymes during freeze-drying. Chem Pharm Bull (Tokyo) 1994;42:5–8. [PubMed]
50. Costantino HR, Andya JD, Nguyen PA, et al. Effect of mannitol crystallization on the stability and aerosol performance of a spray-dried pharmaceutical protein, recombinant anti-IgE monoclonal antibody. J Pharm Sci. 1998;87:1406–1411. doi: 10.1021/js9800679. [PubMed] [Cross Ref]

Articles from AAPS PharmSci are provided here courtesy of American Association of Pharmaceutical Scientists